Commercial satellite system developers received 1 billion yuan in new financing; A full-chain service provider of new automotive retail completed Series A financing Invest Express

TIPS

1. Download the IT Orange APP to track investment and financing events in the primary market at home and abroad in real time. 2. Please indicate that the source is from IT orange (itjuzi521), and the infringement must be investigated. 3. Establish a long-term release cooperation of "Investment Express", please send an email to [email protected].

June 24, 2024

IT 桔子(itjuzi521)

Includes 25 investment/acquisition/IPO queue events

Huimai completed a round of financing of 50 million yuan, led by Meihua Venture Capital and followed by Shunfu Capital, and the first round of financing of Huimai was 50 million yuan, with a valuation of 550 million.

Huimaiche is a full-chain solution provider for new automotive retail, and an Internet high-tech enterprise integrating online system development, brand chain, full-brand trading of automobiles, integration of aftermarket, and new retail of life.

This round of investment will be used to further enhance the leading edge of the high efficiency of the online new retail 2.0 model and the accurate model of new media operation, and simultaneously plan the market investment and expansion of the "Thousands of Cities and Thousands of Stores" plan.

Micro-Nano Star completed the C round of financing of 1 billion yuan and officially became a commercial aerospace unicorn enterprise. This round of financing was led by Oriza Chongyuan-Wuxi Jingkai Shangxian Industrial Investment Fund, followed by Liangxi Science and Technology Innovation Industry Fund of Funds (Bohua Capital Management), and continued to be supported by the old shareholder Qingdao Huizhu Amphora.

Micro-Nano Star is a commercial satellite system development and supplier, mainly engaged in the R&D and manufacturing of complete satellites and providing satellite in-orbit delivery services. The company develops satellite platforms and core components with independent intellectual property rights, has the capabilities of satellite design, production, assembly and integrated testing, and has the ability to develop communication payloads, optical remote sensing payloads and microwave remote sensing payloads, and has the ability to take the lead in grasping the general, coordinating and controlling the overall situation.

Domestic investment events

1. Weibang Zhendian completed nearly 100 million yuan in Series A+ financing

Wipen Medical is a developer of medical imaging technology dedicated to the development of advanced medical imaging technologies for disease diagnosis, treatment, and intraoperative surgical guidance. Relying on the strong scientific research and development capabilities of Purdue University and Vibronix, the company is currently mainly researching the use of optical imaging methods to achieve bacterial resistance screening, as well as the surgical puncture navigation of the kidney. Recently, Weipeng Medical announced the completion of nearly 100 million yuan in Series A+ financing, led by Daoyuan Capital, the old shareholder Fengrui Capital over-invested, and Founder Hesheng followed. This round of funds will be used to promote the rapid commercialization of Weibang Zhendian's spectral analysis products, the iterative development of solutions in the industrial field, and the research and development of ultra-multiplex immunohistochemistry applications.

2. Tingyu Technology completed hundreds of millions of yuan in Series B financing

Tingyu Technology is an edge computing cloud service provider, the company has a self-developed elastic fusion distributed edge computing network and a cloud platform built with a large number of high-quality edge nodes, providing customers with high-performance, high-reliability, high-elasticity and low-cost cloud computing, content distribution and storage services, covering a wide range of industries such as pan-Internet, education, industrial manufacturing and parks. Recently, Tingyu Technology completed a Series B financing of hundreds of millions of yuan jointly led by Guohai Investment and Fosun Ruizheng, followed by Cornerstone Information Innovation, Zhongxiang Venture Capital, Guolian Shares, Sichuan Cultural Investment, Sanqi Mutual Entertainment, Ingenuity Investment, etc., and Yiwei Capital served as the exclusive financial advisor for this round of financing. According to reports, the funds will be used to continuously iterate the research and development of its real-time interactive cloud core technology, as well as to explore the application and implementation of real-time interactive computing power in AI training and inference.

3. Plekang received an investment of 40 million yuan from Shuanglu Pharmaceutical

Plekang Pharmaceutical is an innovative drug developer, focusing on the development of innovative drugs in therapeutic areas such as autoimmune diseases and oncology, with a focus on the development of innovative drugs for biomacromolecules. Recently, Procon received an investment of 40 million yuan, which was exclusively invested by Shuanglu Pharmaceutical, and the raised funds will be used for the research and development of Procon's ophthalmic clinical drug pipeline.

4. Wellcome has received tens of millions of yuan in strategic investment

Based on lipid drop biology, Weikang Pingsheng has developed the world's original "fat body" drug delivery platform, which mimics the natural lipoprotein particles in the human body, and obtains artificial fat bodies through nano preparation technology, which is widely used in the delivery of small molecule innovative drugs, antibodies, nucleic acid innovative drugs, recombinant protein vaccines, nutrients and medicinal extracts. Recently, Weikang Pingsheng has received a strategic investment of tens of millions of yuan, and the investor is Heda Capital.

5. Huahui Intelligent was listed on the New Third Board

Huahui Intelligent is a high-tech enterprise specializing in the R&D, design, production and sales of high-end intelligent equipment and its key components, and is committed to becoming a world-class intelligent equipment manufacturer. Huahui Intelligent will be listed from June 24, 2024. According to the announcement, Huahui Intelligent's operating income from January to October in 2021, 2022, and 2023 will be 28.9545 million yuan, 190.6664 million yuan, and 231.4163 million yuan respectively; The net profit was 1.292 million yuan, 26.571 million yuan and 33.5558 million yuan respectively.

6. Pan-Union Xin'an completed a new round of strategic financing

Panlian Xin'an is a domestic development support basic software developer. Recently, Fanlian Xin'an completed a new round of strategic financing. A number of the company's product lines have made breakthroughs in development and entered the stage of comprehensive acceleration. This round of financing was jointly completed by Junxi Capital, Xingxiang Capital, and Yitong Venture Capital, and Qingke Venture Capital (1945. HK) acted as financial advisor. With this financing, Pan-Union Xin'an will continue to deepen its program analysis technology, carry out dual innovation of core technologies and solutions through deep integration of large model technology, accelerate its efforts to become a leading manufacturer of AI-driven software and hardware development support tools, and fully realize the corporate mission of "AI For Better Code".

7. Chigo Machinery was listed on the New Third Board

Zhigao Machinery is a high-tech enterprise that provides downstream customers with professional comprehensive solutions for rock drilling engineering and aerodynamics, focusing on providing energy-saving, environmentally friendly, safe and efficient drilling rig and screw machine products. Chigo Machinery will be listed on June 24, 2024. According to the announcement, the operating income of Zhigao Machinery from January to September in 2021, 2022 and 2023 will be 880.9031 million yuan, 795.0419 million yuan and 618.2153 million yuan respectively; The net profit was 66.9429 million yuan, 88.9874 million yuan and 60.2538 million yuan respectively.

8. Anke completed tens of millions of Series A financing

Anke is a cyber security technology company that creates a secure, stable and credible cyberspace ecosystem for customers, including governments, enterprises, developers and consumers, through professional security services, and establishes comprehensive cyber security protection for customers. Anke recently completed tens of millions of yuan in Series A financing, led by Jingya Capital, followed by the old shareholder Shunwei Capital, and Crypto Capital served as the exclusive financial advisor. The capital will continue to strengthen product strength and the company's core competitiveness to create value for more customers.

9. National pension insurance received strategic investment

National pension insurance focuses on the business field with pension attributes, is guided by market demand, adheres to the development concept of "inclusive, professional, innovative and safe", and provides the society with differentiated, highly recognizable, commercially sustainable and easy to understand stable and applicable product solutions by promoting the innovation of business management mode and product and service innovation. Recently, the National Pension Insurance has received a strategic investment, and the investor is Allianz Global Investment.

10. Jiuji Technology received tens of millions of yuan in seed round investment

Jiuji Technology is an artificial intelligence developer focused on knowledge work, and the company's first product is a general-purpose office assistant centered on personal data. The company has recently received tens of millions of yuan in seed round investment.

11. 01 Auto received hundreds of millions of yuan in Series A investment

Zero One Auto is a new energy intelligent heavy truck research and development company, based on forward design, research and development of new energy intelligent heavy truck with high-level autonomous driving capabilities. The first batch of products is divided into two models, focusing on the short-distance freight market of new energy heavy trucks. The company has recently received hundreds of millions of yuan in Series A investment, this round of financing is jointly led by the new shareholders Guofa Venture Capital and Shanghai Momenta, and the old shareholders Tianshan Capital and Chentao Capital continue to support it.

Foreign investment events

1. Rapafusyn raises $28 million in Series A financing

Rapafusyn is a non-degradable molecular glue therapeutics developer whose RapaGlues™ library rapidly produces novel chemical entities for challenging or unusable targets, providing promising solutions for drug discovery and development that address unmet medical needs. Recently, Rapafusyn announced the completion of the initial closing of the Series A additional round of financing, with a total amount of $28 million, co-led by Materia Medica Capital and Proxima Ventures, followed by Longpan Investment.

2. Amartha received a strategic investment of $17.5 million

Amartha is a P2P lending company headquartered in Jakarta, Indonesia. Focus on connecting small and micro enterprises with investors, and provide them with simple reception products. Amartha has recently raised $17.5 million in equity financing. The financing was provided by Accion, a global non-profit organization through its Accion Digital Transformation Fund.

3. Qblox raises $26 million Series A financing

Qblox is a quantum control stack developer that empowers quantum computer manufacturers around the world for industrial applications by integrating highly scalable hardware and software solutions. Qblox has successfully closed its Series A funding round, raising a huge amount of $26 million. The investment was led by Quantonation and the Invest-NL Deep Tech Fund, with participation from QDNL and the European Innovation Council (EIC).

4. Iambic Therapeutics获得5000万美元B+轮融资

Iambic Therapeutics(前身为 Entos)是一家人工智能医疗平台开发商,跨多个目标类别和作用机制,快速向诊所提供治疗药物。 近日,Iambic Therapeutics宣布完成超额认购的5000万美元B轮融资,由新投资者 Mubadala Capital 和 Exor Ventures 领投,卡塔尔投资局 (QIA) 以及老股东Abingworth、Illumina Ventures、Nexus Venture Partners、Coatue 和 Tao Capital Partners 参投。

5. BillionToOne raises $130 million in Series D financing

BillionToOne是一家遗传病检测技术研发商。 BillionToOne开发了一种非侵入性替代方案,推出一款新产品UNITY,可以无创检测遗传性疾病。 随着胎儿的发育,少数胎儿细胞死亡,其DNA分子进入母体血液系统。 BillionToOne宣布已在超额认购和规模扩大的D轮融资中筹集了1.3亿美元。 此次融资由Premji Investment牵头,新来的投资者Neuberger Berman和现有投资者(包括Adam Street Partners、Baillie Gifford、Hummingbird Ventures、Civilization Ventures、Libertus Capital和50 Years)参与了此次融资。 普莱姆吉投资公司(PremjiInvest)的AkshayRai领导了D轮,他也将加入亿万通(BillionToOne